Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor
about
Secretory phospholipases A2 induce neurite outgrowth in PC12 cells through lysophosphatidylcholine generation and activation of G2A receptorInternational Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligandsReceptors for acylethanolamides-GPR55 and GPR119GPR119, a novel G protein-coupled receptor target for the treatment of type 2 diabetes and obesityEndogenous and synthetic agonists of GPR119 differ in signalling pathways and their effects on insulin secretion in MIN6c4 insulinoma cellsNovel cannabinoid receptorsNutritional Signaling via Free Fatty Acid ReceptorsStimulation of incretin secreting cellsLysophosphatidylinositol Signalling and Metabolic DiseasesMetabolomics and Type 2 Diabetes: Translating Basic Research into Clinical ApplicationStructural evidence of the species-dependent albumin binding of the modified cyclic phosphatidic acid with cytotoxic propertiesGPR119 agonists for the treatment of type 2 diabetesEarly metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significanceUpregulation of endothelial adhesion molecules by lysophosphatidylcholine. Involvement of G protein-coupled receptor GPR4International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂Identification of an insulin-regulated lysophospholipase with homology to neuropathy target esteraseIndolepropionic acid and novel lipid metabolites are associated with a lower risk of type 2 diabetes in the Finnish Diabetes Prevention Study.Lysophosphatidylcholine activates adipocyte glucose uptake and lowers blood glucose levels in murine models of diabetes.N-oleoyldopamine enhances glucose homeostasis through the activation of GPR119.Inflammatory and Neuropathic Nociception is Preserved in GPR55 Knockout Mice.Novel and emerging diabetes mellitus drug therapies for the type 2 diabetes patientA GPR119 Signaling System in the Murine Eye Regulates Intraocular Pressure in a Sex-Dependent MannerIn vivo metabolite profiling as a means to identify uncharacterized lipase function: recent success stories within the alpha beta hydrolase domain (ABHD) enzyme family.The dual DPP4 inhibitor and GPR119 agonist HBK001 regulates glycemic control and beta cell function ex and in vivoLipid receptors and islet function: therapeutic implications?Molecular matchmaking between the popular weight-loss herb Hoodia gordonii and GPR119, a potential drug target for metabolic disorderMitochondrial Reactive Oxygen Species Mediate Lysophosphatidylcholine-Induced Endothelial Cell Activation.Stimulating β-cell regeneration by combining a GPR119 agonist with a DPP-IV inhibitor.Discovery and characterization of novel small molecule agonists of G protein-coupled receptor 119.Systemic alterations in the metabolome of diabetic NOD mice delineate increased oxidative stress accompanied by reduced inflammation and hypertriglyceremiaG protein-coupled receptors and insulin secretion: 119 and countingEndogenous Ligand for GPR120, Docosahexaenoic Acid, Exerts Benign Metabolic Effects on the Skeletal Muscles via AMP-activated Protein Kinase Pathway.Chemical methods to induce Beta-cell proliferation.Peripheral neural targets in obesityCorrelation of obesity and osteoporosis: Effect of free fatty acids on bone marrow-derived mesenchymal stem cell differentiation.Role of GPR55 during Axon Growth and Target Innervation.Lipid derivatives activate GPR119 and trigger GLP-1 secretion in primary murine L-cells.Gustducin couples fatty acid receptors to GLP-1 release in colon.Seven transmembrane-spanning receptors for free fatty acids as therapeutic targets for diabetes mellitus: pharmacological, phylogenetic, and drug discovery aspects.Fatty acid receptors as new therapeutic targets for diabetes.
P2860
Q24304244-72B73C84-6861-4B74-A416-D2F148FA57EDQ24605072-EE7F3B58-6777-4DC9-8918-B8B9B1A85D0FQ24647538-65BE7B1E-743C-4B94-8E19-645C7A1F714DQ24653673-C92D50A9-8F27-4564-8D7A-89B0AC463343Q24655150-CD913EF2-4E92-490E-A8FE-7825A3538CF0Q24681482-4D4372B1-1905-4CCC-B131-8625B296B61AQ26749828-B045765D-B1DA-47FC-A183-B14FA9CA79ACQ26765259-A900B1C9-87C3-46C3-AD53-B140209C6679Q26771102-779C67FB-37BB-44E1-8479-BB063BEAF36CQ26774386-54D46A92-FA53-42CD-976A-F0A88A95C8A6Q27704759-21016F8C-27AD-477E-A476-398332E7BFF1Q28259606-608A1510-2C05-4E89-956B-3061A764D808Q28279396-A27B12DF-FABE-4F8A-BDDA-7FD4D128F0FAQ28298188-EB6B386C-1982-4AAB-A541-62AB765191B1Q28298445-5A819E76-451B-4B16-BE90-401097FA7332Q28594789-D517F10D-A46F-48A7-9744-5E81BF527941Q33551724-A473E3CA-2ABC-4F5B-8041-8BF6E78077D4Q33553320-28C03807-EB5D-40C7-9229-ECEEEB282A45Q33670471-4FC1B085-B742-4FE0-9E2B-B99106C2AB25Q33681317-589D2588-4F56-490E-AF83-8E87553B088BQ33759570-DFD3ECFB-183F-4DFF-912A-DBCFE0951716Q33792933-7D53DB4A-52C0-4636-AD92-DD05FBD26196Q33801028-2CCF0732-65F5-4746-8396-AA8725E6B49DQ33849176-89E0912A-5937-47FB-BE2A-A3286CFA2838Q33930824-A91CAE59-53EE-404B-80AD-D755C072261CQ34407783-E9765E9A-5C4B-4E18-95D0-F01250AAFA1FQ34524163-3AC9CA7F-A589-4DA4-9D13-CAA436C82A3BQ34575201-B3292527-9F1E-4FD5-B853-38A0AA66BB4BQ35135054-B7D9B7CA-B377-4987-92A6-D9551C5F0240Q35671693-609326E2-F067-496A-998F-C4B9CD093D01Q35867521-562C1C2F-EF97-41D4-A5D4-8EAFAD293B7CQ35953181-62D39CC2-5588-484B-8C6D-47CD03A2EE18Q36090704-9AFAAA3A-9CC1-4FBA-B51A-7B4A10F66FCDQ36166645-39B19554-97BF-4EFB-95E9-CA9506144865Q36244236-0A0661AA-8535-4E0D-856D-8AB5D1E41452Q36426297-84511C01-4A6C-4EE4-A869-D7982D493DD3Q36677839-CFCC6AC0-6EBC-4C21-8069-96E6F9241926Q36699764-B6CDB001-118C-4167-A955-AE3EE641CF1BQ36711136-7B1BF992-B534-4ED3-A480-6DE29B82B85AQ36804437-4E36461B-AC53-4C53-A9F8-E6EB9F150B65
P2860
Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor
description
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2005
@ast
im Januar 2005 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2005/01/28)
@sk
vědecký článek publikovaný v roce 2005
@cs
wetenschappelijk artikel (gepubliceerd op 2005/01/28)
@nl
наукова стаття, опублікована в січні 2005
@uk
مقالة علمية (نشرت في 28-1-2005)
@ar
name
Lysophosphatidylcholine enhanc ...... han G-protein-coupled receptor
@ast
Lysophosphatidylcholine enhanc ...... han G-protein-coupled receptor
@en
Lysophosphatidylcholine enhanc ...... han G-protein-coupled receptor
@nl
type
label
Lysophosphatidylcholine enhanc ...... han G-protein-coupled receptor
@ast
Lysophosphatidylcholine enhanc ...... han G-protein-coupled receptor
@en
Lysophosphatidylcholine enhanc ...... han G-protein-coupled receptor
@nl
prefLabel
Lysophosphatidylcholine enhanc ...... han G-protein-coupled receptor
@ast
Lysophosphatidylcholine enhanc ...... han G-protein-coupled receptor
@en
Lysophosphatidylcholine enhanc ...... han G-protein-coupled receptor
@nl
P2093
P921
P3181
P1476
Lysophosphatidylcholine enhanc ...... han G-protein-coupled receptor
@en
P2093
Hideki Hiyama
Hitoshi Matsushime
Jun Takasaki
Kazuhiro Momose
Kiyoshi Furuichi
Masato Kobori
Masazumi Kamohara
Mitsuyuki Matsumoto
Shigeru Yoshida
Shun-Ichiro Matsumoto
P304
P3181
P356
10.1016/J.BBRC.2004.11.120
P407
P577
2005-01-28T00:00:00Z